Authors: Cannavo, S Squadrito, S Curto, L Almoto, B Trimarchi, F

Citation: S. Cannavo et al., Effectiveness of slow-release lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma, HORMONE MET, 33(10), 2001, pp. 618-624

Authors: Benvenga, S Squadrito, S Saporito, F Cimino, A Arrigo, F Trimarchi, F

Citation: S. Benvenga et al., Myxedema coma of both primary and secondary origin, with non-classic presentation and extremely elevated creatine kinase, HORMONE MET, 32(9), 2000, pp. 364-366

Authors: Cannavo, S Squadrito, S Curto, L Almoto, B Vieni, A Trimarchi, F

Citation: S. Cannavo et al., Results of a two-year treatment with slow release lanreotide in acromegaly, HORMONE MET, 32(6), 2000, pp. 224-229

Authors: Cannavo, S Squadrito, S Finocchiaro, MD Curto, L Almoto, B Vieni, A Trimarchi, F

Citation: S. Cannavo et al., Goiter and impairment of thyroid function in acromegalic patients: Basal evaluation and follow-up, HORMONE MET, 32(5), 2000, pp. 190-195

Authors: Cannavo, S Curto, L Squadrito, S Almoto, B Vieni, A Trimarchi, F

Citation: S. Cannavo et al., Cabergoline: A first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma, J ENDOC INV, 22(5), 1999, pp. 354-359